New Technology Offers Hope for Tinnitus Sufferers, Trains Brain to Ignore Ringing

#ad▼
 SUPPORT UKRAINE  or   TRY AMAZON PRIME  

A recently FDA-cleared therapy trains the brain to ignore the “ringing in the ears” sensation known as tinnitus. Danielle Nottingham reports from Los Angeles.

Report from Cedar Sinai Medical Center in Los Angeles uses the Levo system for treatment for tinnitus sufferers. The Levo System, from OtoHarmonics Corporation in Portland, Oregon is a personal and patented nightly sound therapy designed to improve the quality of a patient’s daily life.

Specifically designed for use during sleep, the Levo system utilizes Apple mobile digital devices to offer user-friendly custom sound therapy based

Statistics show that one in five people suffer from tinnitus, which can affect anyone. Certain groups are more susceptible than others …

Musicians
Construction Workers
Veterans
Pilots & Flight Attendants

See also …

otoharmonics.com


MORE INFO BELOW ADS …




^^ MOBILE? USE VOICE MIC ^^

 facebook … 

GET ALERTS on Facebook.com/ArlingtonCardinal

GET ALERTS on Facebook.com/CardinalEmergencies

GET ALERTS on Facebook.com/ArlingtonHeightsCrime

Get updates from The Cardinal ALL NEWS FEEDS on Facebook. Just ‘LIKE’ the ‘Arlington Cardinal Page (become a fan of our page). The updates cover all posts and sub-category posts from The Cardinal — Arlingtoncardinal.com. You can also limit feeds to specific categories. See all of The Cardinal Facebook fan pages at Arlingtoncardinal.com/about/facebook …


Help fund The Cardinal Arlingtoncardinal.com/sponsor

Arlingtoncardinal.com is an Amazon Associate website, which means that a small percentage of your purchases gets paid to Arlingtoncardinal.com at no extra cost to you. When you use the search boxes above, any Amazon banner ad, or any product associated with an Amazon banner on this website, you help pay expenses related to maintaining Arlingtoncardinal.com and creating new services and ideas for a resourceful website. See more info at Arlingtoncardinal.com/AdDisclosure